Found: 13
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 68, doi. 10.1002/cpdd.790
- By:
- Publication type:
- Article
Mechanism of Chronic Kidney Disease Progression and Novel Biomarkers: A Metabolomic Analysis of Experimental Glomerulonephritis.
- Published in:
- Metabolites (2218-1989), 2020, v. 10, n. 4, p. 169, doi. 10.3390/metabo10040169
- By:
- Publication type:
- Article
Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP‐1366), a novel potassium‐competitive acid blocker, in healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. 763, doi. 10.1111/apt.17406
- By:
- Publication type:
- Article
Featured Cover.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 7, p. i, doi. 10.1111/apt.16796
- By:
- Publication type:
- Article
Pharmacodynamics of tegoprazan and revaprazan after single and multiple oral doses in healthy subjects.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 11/12, p. 1640, doi. 10.1111/apt.16121
- By:
- Publication type:
- Article
Assessment of Oral Vancomycin-Induced Alterations in Gut Bacterial Microbiota and Metabolome of Healthy Men.
- Published in:
- Frontiers in Cellular & Infection Microbiology, 2021, v. 11, p. 1, doi. 10.3389/fcimb.2021.629438
- By:
- Publication type:
- Article
Ursodeoxycholic acid exerts hepatoprotective effects by regulating amino acid, flavonoid, and fatty acid metabolic pathways.
- Published in:
- Metabolomics, 2019, v. 15, n. 3, p. N.PAG, doi. 10.1007/s11306-019-1494-5
- By:
- Publication type:
- Article
Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole.
- Published in:
- Clinical Pharmacokinetics, 2023, v. 62, n. 4, p. 599, doi. 10.1007/s40262-023-01228-4
- By:
- Publication type:
- Article
Pharmacokinetics of Ursodeoxycholic Acid in Elderly Volunteers Compared With Younger Adults in a Korean Population.
- Published in:
- Journal of Clinical Pharmacology, 2019, v. 59, n. 8, p. 1085, doi. 10.1002/jcph.1409
- By:
- Publication type:
- Article
Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 5, p. 1955, doi. 10.1111/cts.13051
- By:
- Publication type:
- Article
Impact of Vancomycin‐Induced Changes in the Intestinal Microbiota on the Pharmacokinetics of Simvastatin.
- Published in:
- CTS: Clinical & Translational Science, 2020, v. 13, n. 4, p. 752, doi. 10.1111/cts.12761
- By:
- Publication type:
- Article
Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-30349-1
- By:
- Publication type:
- Article